Skip to content
Discover insightful articles on UK news, lifestyle trends, …

The Zimbabwean Government Rejects ‘One-Sided’ US Health Aid Package Because of Information Concerns

Medical funding image
The proposed US funding was aimed at programmes for HIV/Aids treatment and prevention, tuberculosis, and malaria.

The nation of Zimbabwe has declined a major American health deal valued at $367m (£272m) over five years because of the United States' insistence on sensitive data.

This move came to light after a internal memorandum dated December was leaked, revealing that President Emmerson Mnangagwa believed the deal was "unbalanced".

A government spokesman later stated that the United States was demanding access to biological samples for scientific study and commercial gain but was unwilling to share the resulting advantages from any future treatments.

"We are forced to start the difficult and regrettable process of ending our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the US had provided more than $1.9bn as health assistance to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has called for further talks to find a deal acceptable to all parties so the country's vital HIV treatment initiative can continue.

Wider Implications

Zimbabwe's decision comes after a similar situation in Kenya, where a court suspended a related deal with the US after legal challenges were filed about the safety of Kenyans' medical information.

After returning to the presidency last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).

The agency had administered aid for the US government, but Trump argued its expenditure was "inefficient" and his administration was pursuing government-to-government deals to enhance openness and responsibility.

According to statements, 16 African countries have to date agreed to these new agreements, representing over $18.3bn in new funding.

Specifics of the Rejected Deal

The money for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this collaboration could have provided extraordinary benefits for Zimbabwean communities, especially the 1.2 million currently receiving antiretroviral therapy through American-funded initiatives," the Ambassador commented.

However, official spokesman Nick Mangwana maintained the arrangement was "unfair".

"Our nation was requested to share its biological resources and data for a long time, with no equivalent assurance of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that shared data," he stated.

"In essence, our nation would provide the raw materials for medical research with no assurance that the resulting innovations would be available to our population should a future pandemic emerge."

National Interest and Global Health

Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were upending structures previously set up through the global health agency.

The spokesperson cited its Pandemic Benefit-Sharing scheme designed to deal with potential global health emergencies.

"This framework is designed to guarantee that when a country provides its data, the benefits – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the resources to develop them."

These objections over the US deal "are not meant as hostility towards the US," Mangwana stressed.

"We are open to continued discussions with our American counterparts on how future collaboration could be structured in a manner that honours the independence and dignity of each country."

Health Experts Response

A leading public health body stated it acknowledged the government's concerns, but suggested that negotiations need to persist since much of the country's Aids initiatives were funded by international support.

"In cases where specific concerns exist, including those involving data governance or agreement terms, these can frequently be addressed via technical clarification and negotiated safeguards," the group said.

This impasse underscores the continuing debate between receiving crucial international aid and safeguarding national sovereignty in an increasingly data-driven world.

By

Katie Miles

A freelance writer and cultural commentator based in London, specializing in UK social trends and urban exploration.

Blog UK Plus

Type to search articles.